chr2-224482072-G-A

Variant summary

Our verdict is Pathogenic.
+10 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 10 classification points (ACMG Germline Pathogenicity v2019). PVS1PM2

The NM_003590.5(CUL3):c.1849C>T (p.Gln617*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 10.00). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

CUL3
NM_003590.5 stop_gained

Scores

6
1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 10.0

Publications

1 publications found
Variant links:
Genes affected
CUL3 (HGNC:2553): (cullin 3) This gene encodes a member of the cullin protein family. The encoded protein plays a critical role in the polyubiquitination and subsequent degradation of specific protein substrates as the core component and scaffold protein of an E3 ubiquitin ligase complex. Complexes including the encoded protein may also play a role in late endosome maturation. Mutations in this gene are a cause of type 2E pseudohypoaldosteronism. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
CUL3 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without autism or seizures
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • pseudohypoaldosteronism type 2E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003590.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 10 points.

PVS1Null variant in LOF gene
Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Stop-gained (exon 14 of 16) at amino acid 617 of 768, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene.
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (threshold 0.0001) — PM2 moderate.

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_003590.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CUL3 NM_003590.5
MANE Select
HGVSc / HGVSpc.1849C>Tp.Gln617*
Exon rankExon 14 of 16
stop_gained
Prot: NP_003581.1UniProt: Q13618-1
CUL3 NM_001257198.2
HGVSc / HGVSpc.1867C>Tp.Gln623*
Exon rankExon 14 of 16
stop_gained
Prot: NP_001244127.1
CUL3 NM_001257197.2
HGVSc / HGVSpc.1651C>Tp.Gln551*
Exon rankExon 13 of 15
stop_gained
Prot: NP_001244126.1UniProt: Q13618-3

Ensembl Transcripts

CUL3 ENST00000264414.9
TSL:1MANE Select
HGVSc / HGVSpc.1849C>Tp.Gln617*
Exon rankExon 14 of 16
stop_gained
Prot: ENSP00000264414.4UniProt: Q13618-1
CUL3 ENST00000409096.5
TSL:1
HGVSc / HGVSpc.1777C>Tp.Gln593*
Exon rankExon 14 of 16
stop_gained
Prot: ENSP00000387200.1UniProt: Q13618-2
CUL3 ENST00000409777.5
TSL:1
HGVSc / HGVSpc.1777C>Tp.Gln593*
Exon rankExon 14 of 16
stop_gained
Prot: ENSP00000386525.1UniProt: Q13618-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:30
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Pathogenic47
BayesDel_addAF
Pathogenic0.63D
BayesDel_noAF
Pathogenic0.66
CADD
Pathogenic48
DANN
Uncertain1.0
Eigen
Pathogenic1.0
Eigen_PC
Pathogenic0.91
FATHMM_MKL
Pathogenic0.99D
GPN-Star LLR
N/A-10
GPN-Star score
N/A10
Mutation Taster
N/A7/193disease causing (fs/PTC)
PhyloP100
Pathogenic10
Showing 12 of 12 scores

Splicing Scores

Pangolin (max)
Uncertain0.25
Pangolin loss
Uncertain0.25
Position offset: 6
SpliceAI score (max)
Benign0.050
Details are displayed if max score is > 0.2
Showing 3 of 3 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.